|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.820 SEK | +5.57% |
|
+11.62% | +21.79% |
| 07-08 | Mendus Completes First Stage Recruitment for Vididencel Trial | MT |
| 07-08 | Mendus completes recruitment for the first part of the VITAL-CML study | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
- Stock Market
- Stocks
- IMMU Stock
- Charts Mendus AB
- Total Return chart
Select your edition
All financial news and data tailored to specific country editions
















